Minerva Neurosciences, Inc. Amortization of Leased Asset
Minerva Neurosciences, Inc. (NERV) reported Amortization of Leased Asset of $101.79 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeasedAsset · last filed 2021-11-08
- Minerva Neurosciences, Inc. amortization of leased asset for the quarter ending 2021-09-30 was $14.94K, a 63.16% decline year-over-year.
- Minerva Neurosciences, Inc. amortization of leased asset for the quarter ending 2021-06-30 was $44.01K, a 11.48% increase year-over-year.
- Minerva Neurosciences, Inc. amortization of leased asset for the quarter ending 2021-03-31 was $42.83K, a 11.40% increase year-over-year.
- Minerva Neurosciences, Inc. amortization of leased asset for the quarter ending 2020-12-31 was $41.68K, a 11.32% increase year-over-year.
- Minerva Neurosciences, Inc. amortization of leased asset for fiscal 2020 was $160.17K, a 11.20% increase from fiscal 2019.
- Minerva Neurosciences, Inc. amortization of leased asset for fiscal 2019 was $144.04K.
| Period end | Amortization of Leased Asset 3 month | Amortization of Leased Asset 6 month | Amortization of Leased Asset 9 month | Amortization of Leased Asset 12 month |
|---|---|---|---|---|
| 2021-09-30 | $14.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $58.95K derived: sum of 2 quarters · filed 2021-11-08 | $101.79K 10-Q · filed 2021-11-08 | $143.47K derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | $44.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $86.85K 10-Q · filed 2021-08-02 | $128.53K derived: sum of 3 quarters · filed 2021-08-02 | $169.08K derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-03-31 | $42.83K 10-Q · filed 2021-05-12 | $84.51K derived: sum of 2 quarters · filed 2021-05-12 | $125.07K derived: sum of 3 quarters · filed 2021-11-08 | $164.55K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-12-31 | $41.68K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $82.23K derived: sum of 2 quarters · filed 2021-11-08 | $121.72K derived: sum of 3 quarters · filed 2021-11-08 | $160.17K 10-K · filed 2021-03-08 |
| 2020-09-30 | $40.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $80.04K derived: sum of 2 quarters · filed 2021-11-08 | $118.49K 10-Q · filed 2021-11-08 | $155.93K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $39.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $77.93K 10-Q · filed 2021-08-02 | $115.37K derived: sum of 3 quarters · filed 2021-08-02 | $151.83K derived: sum of 4 quarters · filed 2021-08-02 |
| 2020-03-31 | $38.45K 10-Q · filed 2021-05-12 | $75.89K derived: sum of 2 quarters · filed 2021-05-12 | $112.35K derived: sum of 3 quarters · filed 2021-05-12 | $147.87K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $37.44K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $73.90K derived: sum of 2 quarters · filed 2021-03-08 | $109.42K derived: sum of 3 quarters · filed 2021-03-08 | $144.04K 10-K · filed 2021-03-08 |
| 2019-09-30 | $36.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $71.98K derived: sum of 2 quarters · filed 2020-11-02 | $106.60K 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $35.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $70.14K 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $34.62K 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |